DTx to support prostate cancer patients undergoing antihormone therapy
- janfjellstrom
- Oct 4, 2020
- 1 min read
Updated: Nov 3, 2020
ScientificMed in collaboration with leading Nordic hospitals and a pharmaceutical company has developed a patient app (Digital Therapeutics, DTx) to support prostate cancer patients undergoing antihormone therapy. The app supports the patients with a targeted exercise program in order to counteract side effects of the therapy.
For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00
Comments